pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 1
    ICG-124
    T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphobla… iCell Gene Therapeutics LLC
  • Phase 2
    ICT-01
    Metastatic Melanoma ImCheck Therapeutics SAS
  • Preclinical
    ICT-568
    Thyroid Cancer Innovative Cellular Therapeutics Co Ltd
  • Phase 1
← prev
page 22 of 62
next →
Pain89
Neurology1
IDE-034
Castration-Resistant Prostate Cancer (CRPC)
$IDYA IDEAYA Biosciences, Inc.
  • Phase 2
    IDE-161
    Colon Cancer$IDYA IDEAYA Biosciences, Inc.
  • Phase 2
    IDE-275
    Endometrial Cancer$IDYA IDEAYA Biosciences, Inc.
  • Phase 2
    IDE-397
    Adenoid Cystic Carcinoma (ACC)$IDYA IDEAYA Biosciences, Inc.
  • Phase 1
    IDE-574
    Breast Cancer$IDYA IDEAYA Biosciences, Inc.
  • Phase 1
    IDE-892
    Esophageal Squamous Cell Carcinoma (ESCC)$IDYA IDEAYA Biosciences, Inc.
  • Phase 1
    IDOV-Immune
    Solid Tumor Viromissile Inc
  • Phase 3
    IFxHu-20
    Merkel Cell Carcinoma TuHURA Biosciences Inc
  • Phase 2
    IGV-001
    Glioblastoma Multiforme (GBM) Imvax Inc
  • Phase 1
    IKS-03
    B-Cell Non-Hodgkin Lymphoma Iksuda Therapeutics Ltd
  • Preclinical
    IKS-04
    Bile Duct Cancer (Cholangiocarcinoma) Iksuda Therapeutics Ltd
  • Preclinical
    IL-2106
    Gastric Cancer iLEAD Biomedical Science Inc
  • Phase 1
    IM-1021
    Diffuse Large B-Cell Lymphoma$IMNM Immunome Inc.
  • Preclinical
    IM-1240
    Adenocarcinoma Of The Gastroesophageal Junction$PPBT PURPLE BIOTECH LTD.
  • Phase 1
    IM-3050
    Solid Tumor$IMNM Immunome Inc.
  • Phase 2
    IMA-203CD8
    Solid Tumor Immatics NV
  • Phase 1
    IMC-002
    Solid Tumor ImmuneOncia Therapeutics Inc
  • Preclinical
    IMC-008
    Gastric Cancer Suzhou Immunofoco Biotechnology Co Ltd
  • Preclinical
    IMM-4701
    Triple-Negative Breast Cancer (TNBC) ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
  • Phase 3
    IMNN-001
    Epithelial Ovarian Cancer$IMNN Imunon, Inc.
  • Phase 2
    IMP-1734
    Fallopian Tube Cancer$EIKN Eikon Therapeutics, Inc.
  • Phase 2
    IMP-9064
    Solid Tumor IMPACT Therapeutics Inc
  • Phase 2
    IMT-009
    Burkitt Lymphoma Immunitas Therapeutics Inc
  • Phase 2
    IMU-131
    Gastric Cancer Imugene Ltd
  • Phase 1
    INB-100
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$INAB IN8BIO, INC.
  • Phase 1
    INB-200
    Glioblastoma Multiforme (GBM)$INAB IN8BIO, INC.
  • Preclinical
    INB-619
    Systemic Lupus Erythematosus$INAB IN8BIO, INC.